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Abstract
Background: Bioactivity profiling using high-throughput in vitro assays can reduce the cost and
time required for toxicological screening of environmental chemicals and can also reduce the need
for animal testing. Several public efforts are aimed at discovering patterns or classifiers in high-
dimensional bioactivity space that predict tissue, organ or whole animal toxicological endpoints.
Supervised machine learning is a powerful approach to discover combinatorial relationships in
complex in vitro/in vivo datasets. We present a novel model to simulate complex chemical-
toxicology data sets and use this model to evaluate the relative performance of different machine
learning (ML) methods.
Results: The classification performance of Artificial Neural Networks (ANN), K-Nearest
Neighbors (KNN), Linear Discriminant Analysis (LDA), Naïve Bayes (NB), Recursive Partitioning
and Regression Trees (RPART), and Support Vector Machines (SVM) in the presence and absence
of filter-based feature selection was analyzed using K-way cross-validation testing and independent
validation on simulated in vitro assay data sets with varying levels of model complexity, number of
irrelevant features and measurement noise. While the prediction accuracy of all ML methods
decreased as non-causal (irrelevant) features were added, some ML methods performed better
than others. In the limit of using a large number of features, ANN and SVM were always in the top
performing set of methods while RPART and KNN (k = 5) were always in the poorest performing
set. The addition of measurement noise and irrelevant features decreased the classification
accuracy of all ML methods, with LDA suffering the greatest performance degradation. LDA
performance is especially sensitive to the use of feature selection. Filter-based feature selection
generally improved performance, most strikingly for LDA.
Conclusion: We have developed a novel simulation model to evaluate machine learning methods
for the analysis of data sets in which in vitro bioassay data is being used to predict in vivo chemical
toxicology. From our analysis, we can recommend that several ML methods, most notably SVM and
ANN, are good candidates for use in real world applications in this area.
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A daunting challenge faced by environmental regulators
in the U.S. and other countries is the requirement that
they evaluate the potential toxicity of a large number of
unique chemicals that are currently in common use (in
the range of 10,000–30,000) but for which little toxicol-
ogy information is available. The time and cost required
for traditional toxicity testing approaches, coupled with
the desire to reduce animal use is driving the search for
new toxicity prediction methods [1-3]. Several efforts are
starting to address this information gap by using relatively
inexpensive, high throughput screening approaches in
order to link chemical and biological space [1,4-21]. The
U.S. EPA is carrying out one such large screening and pri-
oritization experiment, called ToxCast, whose goal is to
develop predictive signatures or classifiers that can accu-
rately predict whether a given chemical will or will not
cause particular toxicities [4]. This program is investigat-
ing a variety of chemically-induced toxicity endpoints
including developmental and reproductive toxicity, neu-
rotoxicity and cancer. The initial training set being used
comes from a collection of ~300 pesticide active ingredi-
ents for which complete rodent toxicology profiles have
been compiled. This set of chemicals will be tested in sev-
eral hundred in vitro assays.
The goal of screening and prioritization projects is to dis-
cover patterns or signatures in the set of high throughput
in vitro assays (high throughput screening or HTS, high
content screening or HCS, and genomics) that are strongly
correlated with tissue, organ or whole animal toxicologi-
cal endpoints. One begins with chemicals for which toxi-
cology data is available (training chemicals) and develops
and validates predictive classification tools. Supervised
machine learning (ML) approaches can be used to
develop empirical models that accurately classify the tox-
icological endpoints from large-scale in vitro assay data
sets. This approach is similar to QSAR (quantitative struc-
ture activity relationship), which uses inexpensive calcu-
lated chemical descriptors to classify a variety of chemical
phenotypes, including toxicity. By analogy, one could use
the term QBAR (for quantitative bio-assay/activity rela-
tionship) to describe the use of in vitro biological assays to
predict chemical activity. The QBAR strategy we describe
here is also related to biomarker discovery from large-
scale -omic data that is used to predict on- or off-target
pharmacology in drug development, or to discover accu-
rate surrogates for disease state or disease progression.
The QBAR in vitro toxicology prioritization approach faces
a number of inter-related biological and computational
challenges. First, there may be multiple molecular targets
and mechanisms by which a chemical can trigger a biolog-
ical response. Assuming that these alternative biological
mechanisms of action are represented in the data, multi-
ple techniques (including ML methods) may be required
to discover the underlying relationships between bio-
assays and endpoint activity. Second, our present under-
standing of biological mechanisms of toxicity (often
referred to as toxicity pathways) is relatively limited, so
that one cannot a priori determine which of a set of assays
will be relevant to a given toxicity phenotype. As a conse-
quence, the relevant features may be missing from the
data set and (potentially many) irrelevant features may be
included. Here, by relevant features we mean data from
assays that measure processes causally linked to the end-
point of interest. By extension, irrelevant features include
data from assays not causally linked to the endpoint. The
presence of multiple irrelevant assays or features must be
effectively managed by ML methods. Third, due to the
high cost of performing the required in vivo studies, there
are limited numbers of chemicals for which high quality
toxicology data is available, and typically only a small
fraction of these will clearly demonstrate the toxic effect
being studied. The small numbers of examples and unbal-
anced distribution of positive and negative instance for a
toxicological endpoint can limit the ability of ML meth-
ods to accurately generalize. In order to develop effective
QBAR models of toxicity, these issues must be considered
in the ML strategy.
Four critical issues for evaluating the performance of ML
methods on complex datasets are: (1) the data set or
model; (2) the set of algorithms evaluated; (3) the
method that is used to assess the accuracy of the classifica-
tion algorithm; and (4) the method that is used for feature
selection. In order to address the first issue, it was neces-
sary to develop a model of chemical toxicity that captured
the key points of the information flow in a biological sys-
tem. The mathematical model we use is based on the fol-
lowing ideas.
1. There are multiple biological steps connecting the ini-
tial interaction of a molecule with its principle target(s)
and the emergence of a toxic phenotype. The molecular
interaction can trigger molecular pathways, which when
activated may lead to the differential activation of more
complex cellular processes. Once enough cells are
affected, a tissue or organ level phenotype can emerge.
2. There will often be multiple mechanisms that give rise
to the same phenotype, and this multiplicity of causal
mechanisms likely exists at all levels of biological organi-
zation. Multiple molecular interactions can lead to a sin-
gle pathway being differentially regulated. Up-regulation
of multiple pathways can lead to the expression of the
same cellular phenotype. This process continues through
the levels of tissue, organ and whole animal. One can
think of the chain of causation between molecular triggersPage 2 of 16
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feedback from higher to lower levels of organization.
3. The number of assays one needs to measure is large,
given our relative lack of knowledge of the underlying
mechanism linking direct chemical interactions with toxic
endpoints.
4. The number of example chemicals for which detailed
toxicology information is available is relatively limited
due to the high cost of generating the data. In most cases,
if a chemical is known to be significantly toxic, further
development and testing is halted, so it is unusual to have
complete, multi-endpoint toxicity data on molecules that
are toxic for any given mode. A corollary is that the
number of positive examples for any given toxicity end-
point will be very limited, rarely making up more than
10% of all cases. This will limit the power to find true
associations between assays and endpoints. A related issue
is that most publicly available data sets that one can use
for toxicology modeling are heavily biased toward posi-
tive or toxic chemicals, because much less public effort is
put into performing extensive studies on chemicals that
are negative examples. The ToxCast data set is addressing
this selection bias by gathering complete data from a set
of chemicals without regard to their ultimate toxicity.
5. The available toxicity endpoint data tends to be categor-
ical rather than quantitative. This is due to the nature of
the in vivo experiments used to evaluate chemical toxicity.
Typically, too few animals are tested under any given con-
dition to pinpoint the lowest effective dose or the rate of
phenotypic toxicity at a particular dose. Instead, if a toxic
effect is seen at a rate statistically above that seen with a
negative control, the chemical will be classified as causing
that toxicity.
We have developed a simple simulation model which
takes into account these ideas. Here we motivate the struc-
ture of the model, while the Methods and Results sections
provide details. We will illustrate the ideas behind our
model with the multiple known pathways that can lead to
rodent liver tumors. Several nuclear receptors, including
CAR (constitutive androstane receptor), PXR (pregnane-X
receptor) and AHR (aryl hydrocarbon receptor), when
activated by a xenobiotic, can upregulate a common set of
Phase I, Phase II and Phase III metabolizing enzyme path-
ways [22-24]. Each of these pathways can, when continu-
ally activated, lead to cellular phenotypes that include cell
proliferation, hypertrophy and cell death. A second, paral-
lel route is activated by compounds that bind to PPARα
(peroxisome proliferator-activated receptor α) and lead to
cellular hypertrophy and cellular proliferation [24,25]. In
a third mechanism, chemicals can directly interact with
DNA, causing the activation of DNA damage repair path-
ways, which can in turn lead to cell death and cellular pro-
liferation. All three of these cellular phenotypes are
potential precursors to liver tumors [26]. This collection
of interconnected direct molecular targets, target-induced
pathways, cellular or tissue phenotypes, and their connec-
tions to the endpoint of liver tumors are illustrated in Fig-
ure 1.
Our model also assumes that a given chemical can interact
with multiple molecular targets. It is well known that
many drug compounds interact with multiple targets, as
reflected in the phenomenon of off-target toxicity. Rele-
vant to the pathways shown in Figure 1, Moore et al
showed that there are compounds that simultaneously
activate both CAR and PXR pathways [27]. Preliminary
data from the ToxCast program allows us to quantify the
magnitude of this multi-target effect. From a set of 183
biochemical targets (primarily receptors, enzymes and ion
channels), the 320 ToxCast chemicals[28] (mostly pesti-
cides) were active against an average of 4.2 targets with a
maximum of 35, a minimum of 0 and a standard devia-
tion of 5.8.
The connections shown in Figure 1 are not deterministic
but instead depend on multiple factors including the
strength and duration of the initial chemical-target inter-
action. Some pathways are more likely than others to lead
to the manifestation of particular cellular processes, and
some cellular processes are more likely than others to lead
to liver tumors. Based on this, one could assign a proba-
bility or strength to each arrow in Figure 1. The probabil-
ity that a given chemical will cause liver tumors is then a
complex integral over the individual step-to-step proba-
bilities, modulated by the target interaction strengths for
the particular chemical.
There is a vast literature on the evaluation of the perform-
ance of different ML methods, but for the present applica-
tion the literature concerning the analysis of microarray
genomics data sets and for QSAR applications are most
relevant. Here we describe a pair of representative studies.
Ancona et al. [29] used three algorithms (Weighted Voting
Algorithm (WVM), Regularized Least Squares (RLS), Sup-
port Vector Machine (SVM)) to classify microarray sam-
ples as either tumor or normal. They examined the
number of training examples that would be required to
find a robust classifier. In their example, SVM and RLS
outperformed WVM. Statnikov et al. studied all of the
major classification issues in the context of multi-category
classification using microarray data in cancer diagnosis
[30]. They compared multi-category SVM (MC-SVM), k-
nearest neighbors (KNN) and several artificial neural net-
work (ANN) implementations and showed that MC-SVM
was far superior to the other algorithms they tested in
their application.Page 3 of 16
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equally vast and extends back for 15 years or more. Much
of this work (like much of QSAR in general) is focused on
the (relatively easy) task of predicting activity against
molecular targets. A representative approach to target
interaction prediction is the paper by Burbridge et al. com-
paring SVM to several other algorithms for the prediction
of binding to dihydrofolate reductase [31]. Lepp et al per-
formed a similar study that showed SVM performed well
in finding predictive QSAR models for a series of 21
molecular targets [32]. The recent state of the science for
predicting whole animal toxicity using ML and QSAR
methods were reviewed by Helma and Kramer [33],
Benigni and Giuliani [34] and by Toivonen et al. [35].
They describe the outcome of an experiment (the Predic-
tive Toxicology Challenge) in which 17 groups submitted
111 models using a training set of 509 NTP compounds
for which mouse carcinogenicity data was available. The
goal was to predict the carcinogenicity of a set of 185 test
compounds. Only 5 of the 111 models performed better
than random guessing and the highest positive predictive
value for these was 55%, and this model had a false posi-
tive rate of 37%. These 5 models[36] include rule-based
methods using chemical fragments plus calculated physi-
cochemical properties, a decision tree model, and one
using a voting scheme across several standard ML meth-
ods. It is difficult to draw many conclusions about the per-
formance of ML methods from this exercise, which failed
to produce significantly predictive methods. The authors
of these reviews speculate that the cause is a combination
of toxicity data being too noisy, the training and test
chemical spaces being too large, and structure based
approaches being inadequate to predict phenotypes as
complex as whole animal toxicity.
One of the key issues in systematically comparing the per-
formance of ML methods is that of estimating accuracy in
an unbiased way. For example, Ntzani and Ioannidis [37]
report that many of the early studies using microarray data
to classify tumor samples did not perform appropriate
cross validation, which has led to inflated predictions of
classification accuracy. This observation prompted our
use of independent validation sets. Molinaro et al.
showed that 10-fold cross validation performed well for
assessing accuracy of genomics classifiers [38]. Leave one
out cross-validation (LOOCV) typically performed some-
what better, but had a significantly higher computational
cost. This was assessed by Molinaro et al. in the context of
using linear discriminant analysis (LDA), ANN, diagonal
discriminant classifiers (DDA), classification and regres-
sion trees (CART) and ensemble classifiers. The Molinaro
study data set (300 samples and 750 independent varia-
Connections between molecular targets, pathways, cellular processes and endpointsFigure 1
Connections between molecular targets, pathways, cellular processes and endpoints. This is illustrated for 5 molecular targets 
(nuclear DNA, and the nuclear receptors CAR, PXR, AHR and PPARα), three molecular pathways, and three cellular pheno-
types, with liver tumors being the final endpoint. The connections have differing strengths or probabilities and are modulated 
by the collection of interactions of a given chemical with the molecular targets.Page 4 of 16
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size to the present work. Baldi, et al. [39] have systemati-
cally addressed the issue of ML performance metrics. They
describe a number of accuracy metrics including the bal-
anced accuracy or Q-score we use in this paper. The Q-
score is the average of the sensitivity and specificity. This
is most useful in the case where the classification variable
is dichotomous and where the number of positive and
negative cases in a training set is not well balanced. They
also emphasize that the actual prediction accuracy is
related to the similarity of the training and test set.
Finally, Sima and Dougherty examined the issue of find-
ing an optimal subset of features with which to train a
classification algorithm [40]. They compare sequential
floating forward search (SFFS)[41] and T-test feature selec-
tion. This latter can fail when variables are only predictive
when they act together. These authors' basic conclusion is
that there are optimal subsets of features, but that poor
classification performance can be due to either a failure to
find an optimal subset or to the inability of any subset to
allow accurate classification. This study examined SVM,
KNN (n = 3) and LDA as classification algorithms. These
authors suggest that automated feature selection methods
have inherent limitations and that one should use biolog-
ically-based selection when possible. Baker and Kramer
used the nearest centroids rule to select small subsets of
genes that could be used as robust classifiers from genom-
ics data sets [42]. Kohavi assessed the behavior of cross
validation methods to assess classifier accuracy for the
C4.5 and Naïve Bayes algorithms [43]. This author con-
cludes that k-fold cross validation with k = 10 provides a
good estimate of classification accuracy balanced against
modest computational requirements.
In summary, the goal of the analyses we present is to eval-
uate a machine learning approach to develop classifiers of
in vivo toxicity using in vitro assay data. In order to develop
an appropriate ML strategy, we generate simulated QBAR
data using a mathematical model whose structure and
parameters are motivated by an idealized biological
response to chemical exposure based on the following
concepts: (a) chemicals interact with multiple molecular
targets; (b) exposure to chemicals can stimulate multiple
pathways that lead to the same toxicological endpoint;
and (c) there are multiple levels of biological organization
between the direct molecular interaction and the "apical"
endpoint. Additional parameters for generating simulated
data include model complexity, the level of noise in the
features, the number of chemicals to be screened and the
number of irrelevant features. We focus on the special case
where there is a large imbalance between the fraction of
positive and negative examples, which is found to be the
case from our toxicological data [44]. The performance of
ML methods is analyzed as a function of these parameters.
Results
We evaluated the performance of different ML methods
on simulated data sets generated by a biologically moti-
vated analytic model. Data sets were simulated based on
two levels of complexity; the number of irrelevant assays
or input features in the data (data not causally connected
with the endpoint being predicted); the number of chem-
icals or instances; and the presence or absence of measure-
ment noise in the data. In all cases, all of the relevant
features (causal for the endpoint being predicted) were
included in the data set.
The network depiction of the simulation models S1 (less
complex) and S2 (more complex) are illustrated in Figures
2 and 3. These networks closely resemble the one shown in
Figure 1, which models the connections leading from direct
molecular interactions with DNA and a variety of nuclear
receptors and to liver tumors. Structurally, the simulation
models are feed-forward networks that causally link direct
molecular interactions (M-nodes) with a final organism-
level toxicity endpoint, by way two levels of intervening
biological processes. Direct molecular interactions trigger
pathway processes (P-nodes) which in turn trigger cellular
processes (C nodes). Only if the cellular processes are acti-
vated to a sufficient level is the final endpoint manifested.
Of equal importance is the fact that many assays will be
measured that are not causally linked to the endpoint.
These irrelevant nodes are termed R-nodes for random. Our
simulations typically include many more R than M nodes
or features. Rules for linking molecular interaction
strengths to the endpoint are described in the Methods sec-
tion. The essential points for the present discussion are that
a given chemical can interact with one or more input nodes
and that the spectrum of input interactions uniquely deter-
mines the value of the endpoint.
The performance of LDA (Linear Discriminant Analysis),
KNN (k-Nearest Neighbors), SVM (Support Vector
Machines), ANN (Artificial Neural Networks), NB (Naïve
Bayes) and RPART (Recursive Partitioning and Regression
Trees) was evaluated both with and without filter-based
feature selection, using 10-way cross-validation testing, as
well as validation with independent data sets which
included 300 instances. For each set of conditions (ML
method, model, number of features, number of chemi-
cals, inclusion of measurement noise, and the presence or
absence of filter-based feature selection), training was car-
ried out on 10 independent samples drawn from a simu-
lated data set of 10,000 chemicals. For all evaluations,
10% of the chemicals were positive and 90% were nega-
tive for the endpoint being predicted. As mentioned pre-
viously, this imbalance between positive and negative
examples reflects the situation with the data sets we are
modeling in which the adverse phenotypes being studied
are rare. Predicted performance was evaluated using K-Page 5 of 16
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ples, we recorded the number of true positives (TP), false
positives (FP), true negatives (TN) and false negatives
(FN), sensitivity and specificity and the balanced accuracy
or Q-score, which is the average of the sensitivity and spe-
cificity. To independently test the performance of the ML
method, an independent validation set was drawn from
the simulated data set and evaluated with the classifica-
tion models for each of the 10 training sets. The results
(TP, FP, TN, FN, sensitivity, specificity, Q-score) from
these 10 data sets were also saved. The approach is out-
lined in Figure 4.
Model S1Figure 2
Model S1. The "M" nodes represent assays that measure direct molecular interactions with a chemical. These interactions can 
activate pathways ("P" nodes) which can in turn activate cellular processes ("C" nodes). Finally, the activation of cellular proc-
esses can lead to the presence of an organ or organism-level endpoint. For Model S1, an additional 300 random or "R" nodes 
were included in the input set of features, so that a total of 308 features are examined. Numerical values shown along edges 
are values of wik used in Equation 1.
Model S2Figure 3
Model S2. All symbols are as described in Figure 1. There are a total of 24 "M" nodes plus 300 "R" nodes for a total of 324 fea-
tures to be examined.Page 6 of 16
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Schematic view of the learning method employedFigure 4
Schematic view of the learning method employed. A large simulated data set is created from the model. From this large data 
pool, multiple independent samples are drawn and either used for cross validation training and validation (X-val) (left hand 
branch) or independent model validation (I-val) (right hand branch). For cross validation training, we use standard K-fold cross 
validation with K = 10. The cross validation performance is the average of the 10 partitions. The classification model ("fit") used 
in the right hand, independent validation branch is constructed using the entire data set for the left hand branch. For each clas-
sifier and each set of conditions, a total of 10 samples are drawn for the cross validation and 10 for the independent validation 
processes. From this collection of results, we derive means and standard deviations for the balanced accuracy or Q-score.
BMC Bioinformatics 2008, 9:241 http://www.biomedcentral.com/1471-2105/9/241The overall performance results of the different ML meth-
ods for the independent validation tests are shown in Fig-
ure 5. All results in this figure are calculated using Model
S1 (Figure 2) for the case where the training and valida-
tion sets contained 300 chemicals or instances. Each panel
shows the Q-score trend for the ML methods as a function
of the number of features included. Horizontal lines are
drawn at Q = 0.9, which is a point that guarantees at least
80% sensitivity and specificity, and at Q = 0.5, which
occurs when sensitivity = 0 (all cases are predicted to be
negative for the endpoint). The far left point is the case
where only the causal features are used. Error bars (± 1
SD) are given for the LDA results to provide an estimate of
the level of variation. The other methods showed similar
levels of variation. The figure shows the Q-Score curves as
a function of increasing number of irrelevant input fea-
tures in four blocks. In each block, each curve shows the
Q-score for one ML method beginning with just the causal
features (Nfeature = 8) and then increasing the number of
irrelevant features until Nfeature = 308. In the first block, the
curves generally show a decrease in performance going
from Nfeature = 8 to Nfeature = 308, which means that the
accuracy of all learning methods generally decreased as
irrelevant features were added.
The response of different ML methods to the addition of
noise varied: LDA and ANN performed the best with only
causal features, while with the maximum number of irrel-
evant features ANN, NB and SVM performed the best and
LDA the worst, at least in the absence of feature selection.
With the exception of LDA, the performance of different
ML methods stabilized after around 100 irrelevant fea-
tures. With the maximum number of irrelevant features
the classification accuracy of KNN and RPART were inter-
mediate between that of the highest group (ANN, SVM,
NB) and the lowest (LDA).
The second block from the left shows the classification
accuracy of the ML methods without feature selection but
with the addition of measurement noise. With no irrele-
vant features the classification accuracy of all ML methods
was significantly lower than in the absence of noise, as
expected. LDA showed the same maximum negative per-
formance trend with the addition of irrelevant features.
The main difference from the previous case (no noise) was
that the performance of KNN (k = 3) was close to that of
ANN, NB and SVM as the number of irrelevant features
increased. As before, RPART and KNN (k = 5) did not per-
form well. In general, the classification performance of
LDA degraded the most with addition of noise while other
methods remained more stable.
The third block from the left shows the classification accu-
racy of the ML methods with filter-based feature selection
Comparison of ML performance for data set S1Figure 5
Comparison of ML performance for data set S1. The y-axis shows the Q-Score and the x-axis is divided into four blocks signi-
fying two different conditions: feature selection (none or filter/t-test) and the measurement noise level (0 or 2). In each block 
the number of input features increases from 8 (all causal for the endpoint) to 308 (300 irrelevant features added). The lines 
show the performance of different ML methods. Error bars (± 1 SD) are provided for the method LDA to indicate the typical 
size of variation.Page 8 of 16
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ance of the ML methods with the first block (no noise, no
feature selection), most ML methods performed better
with feature selection but their overall ranking was the
same. The exception was LDA, which showed the greatest
improvement in performance, tied with SVM and ANN
with the greatest Q-score. Feature selection also decreased
the overall variability in classification performance
between the different ML methods.
The fourth and final block represents the performance
results for the ML methods with noise and the use of T-test
feature selection. Compared with block 2, where feature
selection was not used, the performance of most ML
methods increases slightly. LDA showed a significant
increase in performance. Compared with block 3, the per-
formance of all techniques was significantly lower when
irrelevant features were added. Overall, LDA, NB, SVM,
ANN and KNN (N = 3) were quite stable i.e. their perform-
ance did not vary tremendously with the addition of noise
and irrelevant features.
An alternate way to examine the data is to fix the number
of features and look at trends as a function of number of
chemicals sampled. These curves (not shown) display the
expected trends that as the number of chemicals increases,
there is a corresponding improvement in performance.
The effects of the variant conditions are basically the same
as has already been shown.
Table 1 summarizes the results for both models S1 and S2
for the limiting case where all 300 irrelevant features are
included. For all results, 300 chemicals were used. The
table is organized into 4 blocks, the same as in Figure 5,
but the rows within each block are sorted by decreasing
values of Q-score. Values of sensitivity, specificity or Q-
score > 0.8 are bolded. Rows shaded in gray have Q-score
values less than the best Q-score in that block minus one
standard deviation for the best performing method. From
this table, one can see that specificity is typically high and
that sensitivity is typically low. With a small number of
positive cases, a safe classification scheme is to assume
that most cases will be negative. The ML methods chiefly
differ by their ability to correctly predict the positive cases,
which is reflected in the sensitivity. In all cases, KNN (k =
5) and RPART perform poorly relative to the best ML
method. In the absence of feature selection, LDA also per-
forms poorly. SVM and ANN are always among the best
performers. NB and KNN (k = 3) are intermediate in per-
formance robustness (i.e. relative lack of sensitivity to
added noise and number of irrelevant features). The
trends for model S2 are not significantly different from
those for the simpler model S1. The addition of measure-
ment noise significantly degraded the performance of all
ML methods, and this degradation is mainly reflected in
poorer sensitivity, i.e. the ability to correctly predict posi-
tive cases.
Discussion
Developing predictive classifiers for complex biological
data sets is a challenging problem because there are gener-
ally more features than instances (curse of dimensional-
ity); the classification variable and input features are
noisy; and there are many irrelevant features (i.e. ones
that are measured but which have no causal connection to
the value of the classification variable). We have devel-
oped a test bed for representing biologically motivated
models and have used it to provide insight into the rela-
tive classification performance of different ML methods.
Though true in vitro biological systems are more complex
and dynamic than our model, our approach provides
empirical insight into the relative performance of different
learning methods as a function of the absence and pres-
ence of experimental noise and the number of features. In
particular, we have focused on the situation which is com-
mon in toxicology data sets, namely where there is an
imbalance between the number of positive and negative
examples.
We find several main trends from our simulated data by
systematically analyzing different ML methods on the
same testing, training and validation data. First, most ML
methods perform well in the presence of a small number
of causal features, but most show significant degradation
in performance as irrelevant features are added, which is
well-known [45]. Second, all ML methods perform better
with filter-based feature selection as irrelevant features are
added. Third, the performance depends upon noise in the
input features. While most ML methods perform well in
the absence of noise, some are more stable than others.
Fourth, in the presence of noisy and irrelevant features,
and with feature selection, most ML methods perform
similarly, with the exceptions of RPART and KNN (k = 5)
which performed significantly worse. The models (Figures
2 and 3) resemble generalized artificial neural networks,
leading one to suspect that ANN methods should perform
well. In general this is true, although (see Figure 5) other
methods always performed at least as well.
We found that the accuracy predicted using k-fold cross
validation was statistically indistinguishable from that
seen with an independent validation set except in the case
of KNN (k = 3 or 5) with no feature selection. In this case,
the k-fold cross validation predicted a higher accuracy
than was seen with independent validation. This is the
only situation where we detected over-fitting using the
training data. This phenomenon disappeared when we
tested KNN against a more balanced data set in which
there were equal numbers of positive and negative exam-
ples. All other parameters were unchanged. Issues arisingPage 9 of 16
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Table 1: Performance (mean and SD) of the ML methods.
Model Learner Noise Feature Selection <Sens> SD(Sens) <Spec> SD(Spec) <Q> SD(Q)
S1 ANN 0 None 0.71 0.12 0.96 0.038 0.84 0.068
S1 SVM 0 None 0.68 0.076 0.99 0.0063 0.83 0.039
S2 SVM 0 None 0.66 0.086 0.99 0.0095 0.82 0.041
S2 NB 0 None 0.63 0.13 0.98 0.0072 0.81 0.063
S1 NB 0 None 0.62 0.096 0.99 0.0049 0.8 0.047
S1 KNN(k = 3) 0 None 0.58 0.13 0.98 0.013 0.78 0.067
S2 ANN 0 None 0.56 0.19 0.98 0.008 0.77 0.091
S1 CART 0 None 0.56 0.13 0.96 0.018 0.76 0.065
S2 KNN(k = 3) 0 None 0.47 0.16 0.98 0.014 0.73 0.077
S2 LDA 0 None 0.7 0.11 0.76 0.051 0.73 0.051
S1 KNN(k = 5) 0 None 0.45 0.13 0.98 0.014 0.72 0.064
S1 LDA 0 None 0.66 0.13 0.69 0.048 0.67 0.079
S2 KNN(k = 5) 0 None 0.34 0.1 0.99 0.016 0.66 0.049
S2 CART 0 None NA NA NA NA NA NA
S1 SVM 0 T-test 0.75 0.089 0.98 0.011 0.87 0.043
S1 LDA 0 T-test 0.74 0.11 0.99 0.0057 0.86 0.052
S1 ANN 0 T-test 0.73 0.13 0.97 0.023 0.85 0.055
S2 LDA 0 T-test 0.67 0.11 0.98 0.009 0.83 0.054
S2 ANN 0 T-test 0.7 0.11 0.96 0.013 0.83 0.051
S2 NB 0 T-test 0.65 0.13 0.98 0.014 0.81 0.064
S2 SVM 0 T-test 0.64 0.11 0.98 0.0074 0.81 0.057
S1 NB 0 T-test 0.61 0.078 0.97 0.012 0.79 0.039
S1 KNN(k = 3) 0 T-test 0.55 0.16 0.99 0.008 0.77 0.077
S2 KNN(k = 3) 0 T-test 0.52 0.17 0.99 0.0044 0.76 0.082
S2 CART 0 T-test 0.58 0.12 0.94 0.025 0.76 0.061
S1 CART 0 T-test 0.54 0.17 0.96 0.038 0.75 0.07
S1 KNN(k = 5) 0 T-test 0.45 0.12 1 0.0035 0.73 0.062
S2 KNN(k = 5) 0 T-test 0.37 0.13 0.99 0.0056 0.68 0.066
S1 KNN(k = 3) 2 None 0.54 0.11 0.98 0.011 0.76 0.057
S1 ANN 2 None 0.53 0.13 0.97 0.019 0.75 0.066
S1 NB 2 None 0.48 0.13 0.99 0.0054 0.74 0.067
S2 KNN(k = 3) 2 None 0.49 0.13 0.98 0.0091 0.74 0.065
S2 ANN 2 None 0.44 0.11 0.98 0.016 0.71 0.049
S2 NB 2 None 0.43 0.062 0.99 0.0056 0.71 0.029
S1 SVM 2 None 0.41 0.09 1 0.0031 0.7 0.045
S1 CART 2 None 0.4 0.12 0.94 0.041 0.67 0.053
S2 KNN(k = 5) 2 None 0.33 0.087 0.99 0.0066 0.66 0.043
S2 CART 2 None 0.34 0.17 0.96 0.03 0.65 0.08
S1 KNN(k = 5) 2 None 0.3 0.11 0.99 0.0085 0.65 0.054
S2 SVM 2 None 0.3 0.079 1 0.0039 0.65 0.039
S2 LDA 2 None 0.59 0.069 0.72 0.05 0.65 0.038
S1 LDA 2 None 0.6 0.12 0.64 0.037 0.62 0.068
S1 LDA 2 T-test 0.55 0.11 0.98 0.0078 0.77 0.055
S1 SVM 2 T-test 0.5 0.11 0.99 0.004 0.75 0.053
S2 NB 2 T-test 0.53 0.084 0.98 0.01 0.75 0.042
S1 NB 2 T-test 0.52 0.083 0.98 0.0088 0.75 0.042
S2 LDA 2 T-test 0.52 0.087 0.97 0.011 0.75 0.042
S2 SVM 2 T-test 0.48 0.1 0.99 0.0056 0.74 0.052
S1 ANN 2 T-test 0.51 0.1 0.97 0.015 0.74 0.045
S2 KNN(k = 3) 2 T-test 0.48 0.14 0.99 0.0083 0.73 0.07
S1 KNN(k = 3) 2 T-test 0.48 0.1 0.98 0.01 0.73 0.051
S2 ANN 2 T-test 0.48 0.1 0.96 0.01 0.72 0.049
S1 KNN(k = 5) 2 T-test 0.36 0.095 1 0.0049 0.68 0.047
S2 KNN(k = 5) 2 T-test 0.32 0.047 0.99 0.0036 0.66 0.023
S1 CART 2 T-test 0.35 0.14 0.95 0.023 0.65 0.071
S2 CART 2 T-test 0.25 0.093 0.96 0.027 0.6 0.044
This data is compiled for the special case where 300 chemicals were used, as a function of model, feature selection and level of measurement noise. The 
results are organized into 4 blocks, corresponding to the 4 blocks in Figure 5. Within a block, rows are ordered by decreasing values of Q-Score. The 
results give the average sensitivity, specificity and Q-score along with their corresponding standard deviations. All ML methods were trained using 300 
chemicals. The values come from 10 independent validation runs with unique samples of 300 chemicals. Values of sensitivity, specificity and Q-score > 
0.8 are bolded. Rows where the Q-score is less than that of the best Q-score in the block minus one standard deviation for the best row are shaded.
BMC Bioinformatics 2008, 9:241 http://www.biomedcentral.com/1471-2105/9/241from unbalanced data sets have been previously analyzed.
Japkowicz et al. found that classifier performance of
imbalanced datasets depends on the degree of class imbal-
ance, the complexity of the data, the overall size of the
training set and the classifier involved [46]. Sun et al. also
observed that given a fixed degree of imbalance, the sam-
ple size plays a crucial role in determining the "goodness"
of a classification model [47]. The KNN method is sensi-
tive to imbalanced training data [48,49], and the class dis-
tribution of our simulation data is highly skewed with the
positive to negative rate of 1:9, thus the sample size very
likely explains the different performance between the
training and validation sets.
One of the important limitations of this work is that the
performance of classifiers is biased by our model of chem-
ical-induced bioactivity and toxicity. We assume a static
deterministic model of a biological system without feed-
back. An important aspect of the chemical simulation
model is the use of multiple chemical classes, each of
which contains a collection of chemicals that behave sim-
ilarly (as measured by their molecular interaction spec-
trum). As described in the methods section, a chemical
class is defined by first creating an example of the class by
randomly drawing values for the assay values from a
gamma distribution. The other members of the class are
created through the addition of normally distributed ran-
dom values to each assay value of the chemical class exem-
plar. This process creates a set of (possibly overlapping)
clusters in the high dimensional feature space. We then
draw samples of chemicals from a wide space in which
some clusters contain no chemicals that are positive for
the endpoint, some contain only positive cases, and some
clusters contain a mix of positive and negative cases. One
can qualitatively see how this clustering of feature space
will affect the difficulty of the classification problem by
projecting the chemical space into 2 dimensions and
examining how positive and negative cases cluster. Figures
6 and 7 shows these projections for model S1 (first panel)
and S2 (second panel) using only the causal feature values
for the distance calculation. Projection was performed
using multidimensional scaling (R routine cmdscale).
PCA gives similar results. For model S1 the problem is
approximately separable, so almost any method should
perform well. When all features are included (not shown),
there is more mixing, but still the positive cases tend to
cluster together, so cluster identity (regardless of whether
the causal or the irrelevant features are being used) should
be a good surrogate for classification. In model S2 there is
still a reasonable separation for the case when only the
causal features are included. The presence of a few outly-
Same as Figure 7, except for model S2Figure 7
Same as Figure 7, except for model S2.
Distribution of chemicals in feature/assay space for model and S2Figure 6
Distribution of chemicals in feature/assay space for model 
and S2. The data is projected into 2 dimensions using multi-
dimensional scaling. Chemicals that are negative for the end-
point are indicated by black circles, and chemicals positive for 
the endpoint are represented by red crosses. For ease of vis-
ualization only a randomly selected set of 500 chemicals are 
shown.Page 11 of 16
(page number not for citation purposes)
BMC Bioinformatics 2008, 9:241 http://www.biomedcentral.com/1471-2105/9/241ing, all-positive clusters is very obvious when all features
are included.
We have focused on the performance of single classifiers,
but voting methods which combine the predictions of
multiple individual methods have been used. Statnikov et
al. studied ensemble classifiers or voting schemes, which
attempt to combine multiple sub-optimal classifiers to
improve overall accuracy. That paper evaluated the utility
of selecting very small subsets of genes (as few as 25 out
of > 15,000) for classification. This has the effect of greatly
reducing the danger of over-fitting from small numbers of
samples. Additionally, these authors demonstrated how
to evaluate the comparative performance of different algo-
rithms using permutation testing. Two conclusions from
the Statnikov et al. work on cancer diagnosis using micro-
array data are relevant to the present study. First, they
observe that SVM methods outperformed KNN and ANN.
Our findings show that the relative rankings of these 3
methods is a complex function of the number of irrele-
vant features, the level of noise and the use (or not) of fea-
ture selection. Second, the authors observed that the
ensemble classification methods tended to do worse than
single methods. Although we did not evaluate the per-
formance of ensemble based classification, our results
(Table 1 or Figure 5) do not suggest that voting would lead
to a decrease in performance, as long as the voting rule
was that the chemical was labeled positive if any method
predicted it to be positive.
The present work limited the number of chemicals to 300
and features to 300, which corresponds to the number of
chemicals and assays we are using in the first phase of the
ToxCast program. Despite the relatively small size of the
data set, we were able to evaluate key issues in supervised
learning from noisy and irrelevant data. We plan to
expand the number of features and instance in future
work as we gain additional insights from experimental
data. Additionally, we intend to more fully explore the use
of dimensionality reduction (e.g. through correlation
analysis of closely related features), feature selection and
classifier ensembles in future work.
Conclusion
The prediction of chemical toxicity is a significant chal-
lenge in both the environmental and drug development
arenas. Gold standard in vivo toxicology experiments in
rodents and other species are very expensive and often do
not directly provide mechanism of action information.
The alternative, which has been widely pursued in the
pharmaceutical industry, is to screen compounds using
use in vitro or cell based assays and to use the results of
these assays to prioritize compounds for further efficacy
and safety testing. These in vitro screening techniques are
now being introduced in a significant way into the world
of environmental chemical safety assessment. Here, there
are unique challenges due to the modest amount of in vivo
toxicology data that can be used to develop screening
models, and due to the broad chemical space covered by
environmental chemicals whose toxicology is poorly
characterized. The EPA is carrying out a significant screen-
ing and prioritization program called ToxCast, whose
eventual aim is to screen a large fraction of the commonly
used environmental chemicals and to prioritize a subset
of these for more detailed testing. The present analysis
provides a novel simulation model of the linkage between
direct chemical-target interactions and toxicity endpoints,
and uses this model to develop guidelines for using ML
algorithms to discover significant associations between in
vitro screening data and in vivo toxicology.
We find several main trends from our simulated data set
by systematically analyzing different ML methods on the
same testing, training and validation data. First, most ML
methods perform well in the presence of a small number
of causal features, but most show significant degradation
in performance as irrelevant features are added, which is
well-known [45]. Second, all ML methods perform better
with filter-based feature selection as irrelevant features are
added. Third, while most ML methods perform well in the
absence of measurement noise, some are more stable than
others. Fourth, in the presence of noisy and irrelevant fea-
tures, and with feature selection, most ML methods per-
form similarly well, with the main exceptions being
RPART and KNN which underperformed the other meth-
ods.
Methods
Simulation Models
We use two models of the networks connecting direct
molecular interactions with a test chemical and the pres-
ence or absence of a toxic endpoint. Direct molecular
interactions determine values of the M assays in the mod-
els. These interactions can trigger pathway processes (P-
nodes), which can in turn trigger cellular events (C-
nodes), which can finally lead to the expression of a toxic
endpoint. In addition to the M nodes, there are a large and
variable number of random or R nodes with which a
chemical can interact. Throughout the paper, we refer to
the M and R nodes as causal and irrelevant node or fea-
tures, respectively. A simulated chemical is uniquely char-
acterized by its spectrum of activity for the direct
molecular interaction assays (M + R nodes). The value of
the i-th M (or R) assay for chemical c is given by Mi(c) and
is randomly generated from a gamma distribution (shape
= 3/2, rate = 0.5, ~95% of values are between 0 and 8).
This is the type of distribution one could see for -log(k)
where k is a binding or inhibition constant for a molecule
interacting with protein target Figure 8 shows the distribu-
tion of values for the M and R assays or features.Page 12 of 16
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spectrum of direct physical interactions, they will exhibit
the same downstream biology, including whether or not
they cause the endpoint to be activated. By altering the
interaction strength connecting nodes in the model, one
can simulate differing degrees of coupling between multi-
ple molecular targets and the downstream processes they
control.
These networks simulate the ability for an endpoint to be
triggered by multiple independent mechanisms. In model
S1, there are 2 major mechanisms, driven by the inde-
pendent cellular processes C1 and C2 (see Figure 2). A col-
lection of chemicals may contain some substances that
trigger the endpoint through one mechanism and some
through the other. Some chemicals may trigger both. This
interplay of multiple mechanisms is characteristic of
many toxicological and disease processes and will allow
us to evaluate the ability of classification algorithms to
identify multiple paths from input to output in a biologi-
cal system.
For all P and C nodes, values are calculated using weights
for the edges leading into a node plus the values of the
parents:
where  is the value for node  in level L ∈ [M,
R, P, C, Endpoint] for chemical c, and wik and wijk are
weights for the linear and quadratic interaction terms. The
quadratic term in Equation 1 simulates the presence of
cooperativity between upstream processes that is neces-
sary to trigger downstream processes. In order to test
binary classification algorithms, we assign chemicals to
the positive (1) class if the value of Xi(c) for the endpoint
node is in the top 2% of the distribution, and to the neg-
ative (0) class otherwise. The weights values wik and wijk are
either 1.0 or 0.1 and are assigned sequentially through the
network using the repeating series (1.0, 1.0, 0.1, 0.1, 0.1).
For the simulations, 2 different model networks were
used, called S1 and S2. The networks are shown in Figures
2 and 3. Model S1 has 2 parents for each node. Model S2
has 4 C-level parents of the endpoint, 3 P-level parents for
each C node and 2 M-level parents for each P node. Note
that for S2, certain M-level molecular interactions can trig-
ger more than one of the major mechanisms. Figure 2 dis-
plays the values of the weights used for the linear portion
of the model. Both networks contained a total of 400
input layer nodes or molecular assays (S1: 8 M+392 R; S2:
24 M+374 R), although the simulations only made use of
up to 300 R nodes.
Simulation Data Sets
For each model (S1 and S2), a set of 100,000 chemicals
was created with 2% being assigned to the positive end-
point class. The chemicals are not generated completely
randomly, but were instead created from 500 chemical
classes, each with 200 examples. To create a class, a first
example was randomly generated (M and R assays drawn
from the gamma distribution) and then the other exam-
ples are created from the exemplar by randomly adding
normally distributed variation (SD = 1) to each M and R
assay. The chemical class value (1...500) was retained with
each chemical. From this large set of chemicals, a sam-
pling population was created by drawing 10,000 chemi-
cals from the larger set, but enriching the fraction of
positive cases to 10%. This represents a very broad uni-
verse of chemicals.
From the set of 10,000 chemicals, multiple samples were
drawn and used in the classification training and testing
process. The only data given to the classification algo-
rithms are the values for the M and R assays or features
and the endpoint classification. A sample was character-
ized by the following variables:
1. Model (S1, S2)
X c w X c w X c X ci
L
ij j
L
j
ijk j
L
k
L
jk
+
= +∑ ∑1 12( ) ( ) ( ) ( )
(1)
X ci
L( ) N ci
L( )
Distribution from which the M and R assay values are drawnFigure 8
Distribution from which the M and R assay values are drawn. 
This is a gamma distribution with shape = 3/2 and rate = 0.5Page 13 of 16
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3. The number of random or irrelevant features (R nodes)
(50,100,200,300)
4. Whether or not measurement noise was added to the
original M and R assay values. If so, normally distributed
noise (SD = 2) was added to each assay's value.
Classification Methodology
Each classification algorithm or ML method was evaluated
using the balanced accuracy or Q-score [39], which is the
average of the sensitivity and specificity for prediction.
This is a useful metric in the present situation because the
fraction of positive cases is small and the Q-score gives
equal weight to the accuracy of predicting positive and
negative cases. In each sample, the fraction of chemicals
that is positive for the endpoint is small (10%), so a good
first approximation would be to predict that all chemicals
will be negative for the endpoint. The Q-score for this
default prediction is 0.5, whereas a perfect prediction will
score 1.0.
Each ML method was evaluated against a set of 10 samples
or training sets, each using k-wise cross validation, with k
= 10 [43]. The model that was produced from each of the
training samples was evaluated against a separate valida-
tion sample. The training and validation samples were
drawn from the same distribution. We calculated distribu-
tions of Q-score for both the training samples (the results
of the k-fold cross validation) and the validation samples.
We call these the "predicted" and "true" Q-scores.
For each sample set described above, we evaluated per-
formance for a series of ML methods with no feature selec-
tion and with T-test filter feature selection. In the latter
case, the best 20% of features were selected, with a mini-
mum number of 8. (Note that the features (M-nodes) are
not strictly normally distributed, but are instead drawn
from a gamma distribution overlaid with normally dis-
tributed variation.) To manage the large number of indi-
vidual runs, a simple MySQL database was created with 2
tables called queue and result. The queue table contains all
run parameters and the result table holds all of the rele-
vant results. The relevant parameters in the queue table
are [model (S1, S2), measurement noise (0/2), number of
features, number of chemicals, ML method, feature selec-
tion mode (none or T-test)]. In all cases, the fraction of
positive cases in the sample was 10%. Figure 4 illustrates
the overall approach.
Classification Algorithms/ML methods
Table 2 lists the ML methods that were evaluated, along
with any non-default parameters. Parameters for each of
the machine learning methods were tuned so that the per-
formance (Q score) was acceptable (> 0.9) when tested
against model S1 when the ML method was presented
with all of the true features, no irrelevant features, and
when no noise was added to the features. Default param-
eters were used for KNN, NB, LDA and RPART. For SVM,
the cost function was varied over the range from 1 to 1000
and a value of 100 was selected. ANN was the only
method requiring significant tuning. Approximately 20
combinations of the parameters listed in Table 1 were
tested prior to arriving at an acceptable set. All code was
written in R (version 2.5.1) using the MLInterfaces imple-
mentation of all ML methods. The code was parallelized
using snow and Rmpi and run on a Linux workstation
cluster and an SGI Altix 4700.
List of abbreviations
The following abbreviations are used in the manuscript:
ML: Machine Learning; KNN: k-Nearest Neighbors; NB:
Naïve Bayes; LDA: Linear Discriminant Analysis; SVM:
Support Vector Machine; ANN: Artificial Neural Network;
CART: Classification and Regression Trees; RPART: Recur-
sive Partitioning and Regression Trees; HTS: High
Throughput Screening; HCS: High Content Screening.
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